FDA Device recall Z-1484-2026
Atellica CH Urine Albumin (UAlb)
- FDA Device
- Class II
- ongoing
- Published 2026-03-11
On 2026-03-11 the FDA classified a Class II recall of Atellica CH Urine Albumin (UAlb) by Siemens Healthcare Diagnostics, citing falsely depressed UAlb patient results may occur. Affected samples with any urine albumin concentration above the UAlb measuring interval >40.0 mg/dL may report values between 6.2….
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1484-2026 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2026-01-20 |
| Published | 2026-03-11 |
| Last updated | 2026-09-13 11:58 UTC |
| Company | Siemens Healthcare Diagnostics |
| Distribution | US |
Product
Atellica CH Urine Albumin (UAlb). Material Number: 11537225
Reason
Falsely depressed UAlb patient results may occur. Affected samples with any urine albumin concentration above the UAlb measuring interval >40.0 mg/dL may report values between 6.2 mg/dL and 40.0 mg/dL.
Identifiers
| code_info | Material Number: 11537225. UDI-DI: 00630414611099. Lot Numbers: All lot numbers. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1484-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.